Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Despite decades of research, cancer remains a growing global health challenge. Nanomaterials-based therapeutics have shown promise, but their clinical applications are often limited by poor selectivity and undesirable side effects. Recently, deoxyribonucleic acid (DNA) based nanomachines have gained attention as intelligent drug carriers due to their ability to precisely target specific organelles. By leveraging rationally designed DNA nanomachines, it is possible to directly attack subcellular structures or deliver therapeutic agents to precise locations, triggering organelle-mediated cell death. This innovative approach offers several advantages, including enhanced efficacy, lower dosages, minimized off-target effects, reduced multidrug resistance, and improved therapeutic durability. This review explores the history and advancements of organelle-targeting strategies, providing new insights into targeting the nucleus, mitochondria, endoplasmic reticulum, Golgi apparatus, and lysosomes using DNA nanomachines. The review also discusses the structures, design principles, and therapeutic mechanisms of these nanomachines, along with the integration of artificial intelligence-driven self-driving laboratories to enhance research growth, efficiency, and competitiveness. Finally, the current challenges, opportunities, and future directions in this evolving field are addressed, offering a roadmap for solving the intricate maze of organelle-targeted cancer therapies.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1002/adma.202508047 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
A cascade amplification platform integrating entropy-driven DNA nanomachine with CRISPR/Cas12a for microRNA-21 and Listeria monocytogenes detection.
Biosens Bioelectron
September 2025
State Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious Diseases, Key Laboratory for Zoonosis Research of the Ministry of Education, School of Public Health, Jilin University, Changchun, 130021, China. Electronic address:
As one of enzyme-free amplification strategies, entropy-driven catalytic (EDC) based on toehold-mediated strand displacement reaction could achieve efficient amplification without cumbersome temperature changing and expensive enzymes, which shows great potential in biological sensing. However, the limitations in reaction velocity and sensitivity need to be further improved. Herein, a cascade platform integrating entropy-driven DNA nanomachine with CRISPR/Cas12a was proposed.
View Article and Find Full Text PDFAsymmetric T-segment binding and gate dynamics govern the final stages of the type IIA topoisomerase catalytic cycle.
Int J Biol Macromol
August 2025
Theory Department, National Institute of Chemistry, Hajdrihova 19, 1000 Ljubljana, Slovenia; University of Ljubljana, Faculty of Pharmacy, Aškerčeva 7, 1000 Ljubljana, Slovenia. Electronic address:
Type IIA DNA topoisomerases are molecular nanomachines that alter DNA topology during essential cellular processes. The final steps of their catalytic cycle, after translocation of the transported (T-) segment into the C-gate, are still not fully understood. Here, we performed all-atom molecular dynamics simulations of several conformational states of Saccharomyces cerevisiae topoisomerase IIA, each with a T-segment inserted into the C-gate.
View Article and Find Full Text PDFDNA Photofluids: An Innovative Breakthrough in Mimicking Cellular Life Behaviors.
Research (Wash D C)
August 2025
The International Peace Maternity and Child Health Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200030, China.
Current molecular machines face substantial challenges in coordinating their actions in space and time to generate cell-like macroscopic motions. A recent study in introduced a light-responsive artificial DNA nanomachine based on liquid-liquid phase separation technology-photofluids. By applying different light stimuli for spatiotemporal control, this nanomachine system successfully mimics typical cellular behaviors such as division, deformation, pseudopod extension, and rotation at the macroscopic scale for the first time.
View Article and Find Full Text PDFSpherical nucleic acids-based nanomachines enable in situ tracing of exosomal lncRNA at the single-vesicle level.
Biosens Bioelectron
August 2025
School of Laboratory Medicine, Hubei University of Chinese Medicine, 16 Huangjia Lake West Road, Wuhan, 430065, PR China; Hubei Shizhen Laboratory, Wuhan, 430065, Hubei, PR China. Electronic address:
Exosomal long non-coding RNAs (lncRNAs) serve as promising, non-invasive biomarkers for further cancer therapy. Conventional techniques for detecting exosomal lncRNAs often rely on exosome lysis and total RNA extraction. Direct, non-destructive tracking of exosomal molecular cargoes is thus crucial for the precise and high-fidelity detection of exosomal lncRNAs.
View Article and Find Full Text PDFDNA nanotechnology in oligonucleotide drug delivery systems: Prospects for Bio-nanorobots in cancer treatment.
Adv Drug Deliv Rev
August 2025
Pennsylvania State University, University Park, PA, USA. Electronic address:
DNA-based nanomaterials have demonstrated significant potential in various applications due to their unique properties, including DNA's diverse molecular interactions, programmability, and versatility with biological modules. Meanwhile, the DNA origami platforms have shown promise in the creation of drug carriers. This technique has paved the way for the production of nanomachines with outstanding performance.
View Article and Find Full Text PDF